Werner Meier

CSO at Revitope where we are building highly specific T cell redirector bispecifics and a company with focus on combining great science, great people and great culture. Visiting Scientist, Biogen Research responsible for guiding selected high-impact drug discovery initiatives. Vice President of Biologics Drug Discovery, Biogen Research responsible for developing therapeutic protein candidates. Guided the design, expression, characterization and development transition of over two dozen novel protein therapeutics that included antibodies and their derivatives, receptor-Ig fusion proteins and bispecific antibodies. Program Director for two development programs aimed at treating immunologic and neurological diseases and successfully guided the programs through preclinical development and manufacturing into early clinical studies.